Anthony Féral graduated with a Master’s degree in Chemistry of Biomolecules: Research and Innovation from the University of Montpellier (France). During his Master’s internships, he worked on the synthesis and the rational design of pseudopeptides, then he worked on the elaboration and the synthesis of small-molecule-based PROTAC compounds. These two internships were performed at the IBMM, in the team Amino Acids, Heterocycles, Peptides and Proteins. From April 2021 to September 2022, Anthony worked as an engineer with Dr. Lubomir Vezenkov and the start-up MT-Act, on the conception of therapeutic pseudopeptides and PROTACs. Since October 2022, Anthony has been a CIFRE PhD student with the MT-act society and the team Amino Acids, Heterocycles, Peptides and Proteins under the supervision of Dr. Muriel Amblard and Dr. Lubomir Vezenkov. He works on the synthesis of compounds that target the brain to treat neurodegenerative diseases.